Esposito Silvano, Ianniello Filomena, Noviello Silvana, Leone Sebastiano, Ascione Tiziana, Tice Alan, Maiello Angostino, de Lalla Fausto, Girmenia Corrado, Marranconi Franco, Serrentino Giuseppe, Iaccarino Angello, Di Cianni Ernesto
Departimento di Malattie Infettive Seconda Università degli Studi di Napoli, Italy.
Infez Med. 2002 Sep;10(3):169-75.
In the early eighties, in the US the advantages (reduced costs, no hospitalisation trauma in children, no immobilization syndrome in elderly, reduction of nosocomial and acquired infections by multi-resistant organisms) of OPAT were identified and suitable therapeutic programs were established. Following the US experience, other countries set up their own OPAT programs which vary considerably from country to country because of different ways in which infections are managed in different parts of the world and because of different reimbursement systems. In order to understand the ways of managing OPAT and its results, a National OPAT Registry was set up in 1999 in Italy belonging to a wider International OPAT database, which collects data also from USA, Canada, Spain, Uruguay and Argentina. Up to now 396 patients and as many antibiotic courses have been included in the National Registry by eight different centres. The analysis of data permits to get information about the criteria of patient's selection, treatment (route of administration, site of care, choice of antibiotic, dosage and duration), outcomes and possible side-effects. Italian results offer a quite peculiar picture of OPAT in this country when comparing data with those of other countries. In contrast with other countries where soft tissue infections and osteomyelitis are the most frequent diagnoses for including patients in OPAT programmes, in Italy pneumonia and bronchitis are the top two amenable infections. Ceftriaxone, Teicoplanin and Amikacin are absolutely the top three antibiotics selected for OPAT in Italy which confirm that a single daily dose regimen represents a great advantage in terms of compliance. Finally, a large percentage of antibiotic courses (50%) are carried out by using the i.m. administration route, which is very unusual in other countries. OPAT Registry is still ongoing and it will give us more detailed information in the future about the management of infections in the outpatient setting, but it already permits to define an actual picture of OPAT in our country and/or to compare and correlate data and information from different countries.
20世纪80年代初,美国发现了门诊抗菌药物治疗(OPAT)的优势(降低成本、避免儿童住院创伤、避免老年人出现制动综合征、减少多重耐药菌引起的医院感染和获得性感染),并制定了合适的治疗方案。借鉴美国的经验,其他国家也建立了各自的OPAT项目,由于世界各地感染管理方式不同以及报销系统不同,这些项目在不同国家差异很大。为了了解OPAT的管理方式及其效果,1999年意大利建立了国家OPAT登记处,该登记处属于一个更广泛的国际OPAT数据库,该数据库也收集来自美国、加拿大、西班牙、乌拉圭和阿根廷的数据。到目前为止,八个不同的中心已将396名患者及同样数量的抗生素疗程纳入国家登记处。数据分析有助于获取有关患者选择标准、治疗(给药途径、护理地点、抗生素选择、剂量和疗程)、治疗结果及可能的副作用的信息。将意大利的数据与其他国家的数据进行比较时,意大利的结果呈现出该国OPAT的相当独特的情况。与其他国家不同,在那些国家软组织感染和骨髓炎是将患者纳入OPAT项目最常见的诊断,而在意大利,肺炎和支气管炎是最适合进行OPAT治疗的两种感染。头孢曲松、替考拉宁和阿米卡星绝对是意大利OPAT选用最多的三种抗生素,这证实了每日单次剂量方案在依从性方面具有很大优势。最后,很大比例(50%)的抗生素疗程是通过肌内注射途径进行的,这在其他国家非常少见。OPAT登记处仍在进行中,未来它将为我们提供更多关于门诊感染管理的详细信息,但它已经能够描绘出我国OPAT的实际情况,和/或比较并关联来自不同国家的数据和信息。